http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102206203-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_caacf483b6be9ae2d2677103a70559db
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
filingDate 2011-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cee0dcc37d98b9163aa808e06da9f83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17192db503734d4b43d23214a6937ed8
publicationDate 2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102206203-B
titleOfInvention Synthesis of benzimidazole-containing naphthalimide derivatives and applications of benzimidazole-containing naphthalimide derivatives on cancer resistance
abstract The invention relates to synthesis of benzimidazole-containing naphthalimide derivatives and applications of the benzimidazole-containing naphthalimide derivatives on cancer resistance, and belongs to the field of organic synthesis and pharmaceutical chemistry technology. The benzimidazole-containing naphthalimide derivatives are obtained through a method that a benzimidazole group is introduced into a fourth position of a naphthalene ring of naphthalimide. Experiments of proliferation inhibiting effects of the benzimidazole-containing naphthalimide derivatives on cancer cells adopt a microculture tetrozolium (MTT) reduction method and aim at MCF-7 human breast cancer cells, Hela human cervical cancer cells and PC12 rat adrenal medullary pheochromocytoma differentiated cells. Results of the experiments show that the benzimidazole-containing naphthalimide derivatives have the advantages of good inhibitory activity against cancer cells and good selectivity on cancer cells.
priorityDate 2011-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426044748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457492341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415734111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450260148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID327044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415940985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424599094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409283606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4684814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546775

Total number of triples: 44.